Our study demonstrates that T14, a 14-mer peptide associated with Alzheimer’s disease, impairs autophagy via the mammalian target of rapamycin complex 1, contributing to the progression of the pathology. This finding adds a new layer of understanding to how T14 may promote neurodegeneration.
LATEST NEWS
- CEO & Founder Baroness Susan Greenfield features in the Databird business journal!
- Neuro-Bio attended the London Biotechnology Show – Wednesday 18th June
- Catalina Vigil Cardenal’s farewell message
- Baroness Susan Greenfield attends the Freeths Annual Life Science Summit on 15th May
- Neuro-Bio welcomes Michelle Vandekleut!